VALERIE THOMLEY: Open Payments
NPI 1831570670 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 40 payments from 12 companies in 2025. Trend: 2023 $419 · 2024 $682 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $205 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Exact Sciences Corporation | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $33 |
| ABBVIE INC. | 2 | $30 |
| Ethicon US, LLC | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: MOUNJARO, FARXIGA, JARDIANCE, Kerendia, The Cologuard Plus Collection Kit, Auvelity, AIRSUPRA, Ozempic.
Industry payments across AL — which companies pay providers there.
